Olverembatinib (GZD824) dimesylate

Olverembatinib (GZD824) dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.

Price Not Available 1g Olverembatinib (GZD824) dimesylate Supplier Page

Trivial name	HQP1351 dimesylate
Catalog Number	S7194
Molecular Formula	C29H27F3N6O.2CH4O3S
CAS#	1421783-64-3
Inchi	InChI=1S/C29H27F3N6O.2CH4O3S/c1-19-3-5-22(14-21(19)6-4-20-13-24-17-34-36-27(24)33-16-20)28(39)35-25-8-7-23(26(15-25)29(30,31)32)18-38-11-9-37(2)10-12-38;21-5(2,3)4/h3,5,7-8,13-17H,9-12,18H2,1-2H3,(H, 35,39)(H,33,34,36);21H3,(H,2,3,4)
Inchi Key	LEVIGHXVOVROGW-UHFFFAOYSA-N
SMILES	CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CC5=C(NN=C5)N=C4.CS(=O)(=O)O.CS(=O)(=O)O
Size	1g
Supplier Page	http://www.selleckchem.com/products/gzd824.html
Additional Information	https://file.selleck.cn/downloads/struct/GZD824-chemical-structure-s7194.gif